Find an expert

A/Professor Tripathi is a Vascular and Endovascular Surgeon in Brisbane and Wide Bay areas. He is an Adjunct Professor at University of Sunshine Coast and Associate Professor at Faculty of Medicine and School of Biomedical Sciences at University of Queensland.

He is a Fellow of the Royal Australasian College of Surgeons in Vascular Surgery, a senior member of Royal Australasian College of Surgeons' Academy of Surgical Educators and of the Section of Academic Surgery.

He is a Distinguished Fellow of Society for Vascular Surgery (USA) and of American Venous Forum (AVF). He was conferred with an Honorary Membership of European Venous Forum for his outstanding contribution to art and science of venous surgery in 2018. He is also the 2017 recipient of Asterios Katsamouris Lecture by the European Society for Cardiovascular Surgery. He was inducted into Sigma Xi Honors Research Society in 2017. He frequently lectures to professional societies and leading vascular and Endovascular conferences throughout the world.

Dr Tripathi’s academic recognition includes distinguished visiting Professorships to Division of Vascular and Endovascular Surgery of Stanford University, Palo Alto, California, USA and Mayo Clinic and Mayo School of Medicine, Rochester, USA, University of Saint Louis, St Louis, USA, Karolinska University Hospitals, Stockholm, Sweden, University of British Columbia, Vancouver, Canada and University of Lisbon, Portugal.

Dr. Tripathi is an associate editor of Journal of Endovascular Therapy and sits on the editorial boards of Journal of Vascular Surgery, Journal of Cardiovascular Surgery, Vascular, Phlebology, Aorta, International Angiology, Asian Journal of Surgery, Endovascular Today and Vascular Disease Management. He is a distinguished reviewer for European Journal of Vascular and Endovascular Surgery and Journal of Vascular Interventional Radiology.

Professor Kylie Tucker leads a positive research environment, where exceptional basic science and clinical researchers come together to advance knowledge about muscles and movement control. Her work has transformed our understanding of how pain impacts movement; showcased methods for estimating muscle forces; and advanced the assessment of childhood movement control and adolescent skeletal maturity. Recently, Kylie has drawn on her fundamental science knowledge to propose a shift in our understanding of the potential drivers of scoliosis progression. Approximately one child in every Australian classroom, and 3-7% world-wide, will develop adolescent idiopathic scoliosis. There is no known cause, nor strong evidence to determine when or where to target non-invasive treatment. Each year in Queensland >200 adolescents have up to 12 vertebrae fused as conservative treatment has not stopped their curve progression. Her group have identified unique, targetable muscle features, that can be non-invasively detected early in curve progression.

In parallel to her research, Kylie teaches about muscles and movement control across 10 UQ programs, where class size ranges from 70-1400 students. Within the School of Biomedical Science she was the Deputy Director Teaching and Learning (2018-20), the inaugural chair of the people centred, REMEDE committee (2021-23); and Director of Teaching and Learning (2024-3/25). Kylie co-facilitates UQ’s flagship Career Progression for Women program (2024- ), and intentionally fosters a supportive academic culture, empowering academics in their pursuit of excellence, across all her roles. She is the current (2024-26) President of the International Society of Electrophysiology and Kinesiology (ISEK); a global organization composed of 375 members in health-related and basic science fields with a common desire to study human movement and the neuromuscular system. Kylie has contributed to the leadership of this society since 2018.

Karen Tuesley is an early career researcher and Lecturer in epidemiology at the School of Public Health, University of Queensland. Karen’s research focuses on women’s health and cancer epidemiology using large longitudinal datasets. Her PhD research used large-scale data to explore the associations between the use of chronic disease medications and the risk of ovarian cancer. She also researches long-term health outcomes for women after gynaecological surgery. Karen works with large observational studies with longitudinal data and is experienced with different analytic techniques and methods including emulated trials and Mendelian randomisation.

Dr. Kelvin Tuong is a Senior Research Fellow/Group Leader at the Ian Frazer Centre for Children’s Immunotherapy Research (IFCCIR), Child Health Research Centre. He is interested in single-cell analysis of immune cells and harnessing adaptive immune receptors for understanding immune cell development and function in health and in cancer.

Dr. Tuong was born and raised in Singapore and moved to Brisbane, Australia, after completing national service in Singapore and obtaining a Diploma in Biomedical Laboratory Technology (Ngee Ann Polytechnic).

Dr. Tuong was originally trained as a molecular cell biologist and gradually transitioned into bioinformatics during his post-doctoral training. He has been very prolific for an early career researcher, having published >70 articles since 2013, with nearly a third of them as first/co-first or last author and has a stellar track record of pushing out highly collaborative work in prestigious journals including Nature, Cell, Science, Nature Medicine, Nature Biotechnology J Exp Med etc. He has the rare combination of having excellent laboratory and bioinformatics skill sets which provide him a strong command of both fundamental immunology and computational approaches.

Dr. Tuong completed his undergraduate Bachelor's degree in Biomedical science with Class I Honours, followed by his PhD in macrophage cell biology and endocrinology at UQ (Prof. Jenny Stow lab and Emiritus Prof. George Muscat lab, IMB, UQ). He then went on to a post-doc position with Emiritus Prof. Ian Frazer (co-inventor of the Gardasil cervical cancer vaccine, UQ Frazer Institute, Translational Research Institute) where he worked on HPV immunology, cervical cancer and skin cancer. In his time in the Frazer lab, he developed an interest in bioinformatics analyses as a means to tackle and understanding immunology problems in health and disease. He then moved to the UK and joined Prof. Menna Clatworthy's lab at the University of Cambridge and Dr. Sarah Teichmann's lab at the Wellcome Trust Sanger Institute. He has focused his interests on single-cell analyses of tissue immune cells, including T and B cells and their specific receptors (TCR/BCR). He has developed bespoke bioinformatics software, including one tailored for single-cell B Cell Receptor sequencing analysis, Dandelion, which he used in one of the largest combined single-cell transcriptomic, surface proteomic and TCR/BCR sequencing dataset in the world, published in Nature Medicine, and more recently in Nature Biotechnology where we introduced a TCR-based pseudotime trajectory analysis method.

Dr. Tuong is now leading the Computational Immunology group at the IFCCIR and his lab is focused on investigating how pediatric immunity is perturbed during cancer at the cellular level and how this information can be used for creating novel warning systems for children with cancer. For potential students/post-docs/trainees interested in joining the team, please contact Dr. Tuong at z.tuong@uq.edu.au.

Karen Turner is a clinical psychologist and research academic. She is Deputy Director at the Parenting and Family Support Centre. Her research activity focuses on the impact of evidence-based parenting support on child, family and community outcomes. She is a foundational co-author of the Triple P – Positive Parenting Program and has published more than 50 professional manuals, parent workbooks, tip sheet series, and video programs, which are currently being used in 27 countries, in 20 languages. She has also co-written television segments and four interactive online parenting programs. She has clinical and research experience relating to parent wellbeing, child development, and the prevention and treatment of a variety of childhood behavioural and emotional problems, including work with feeding disorders, pain syndromes and conduct problems. Her research has also focused on the development and evaluation of brief primary care interventions in the prevention of behaviour disorders in children, and the dissemination of these interventions to the professional community. She has also conducted series of research into: online delivery of parenting programs; the cultural tailoring of mainstream parenting programs for Indigenous families; and enhancing the training and post-training environment for Indigenous professionals. Her current work includes further resource development for primary care settings, early education settings, and an ongoing focus on making evidence-based parenting support programs more accessible for First Nations families, and in low-resource and developing communities.

Dr Turpin’s research centres on the clinical/professional reasoning of occupational therapists across the spectrum of experience from new graduates to experts, as well as the subjective experiences of people with disabilities. She specialises in the use of qualitative research methods and uses a variety of qualitative research methods in her own research, as well advising others on these research methods. Dr Turpin has written books and book chapters on occupational therapy models of practice, evidence-based practice, and clinical reasoning, as well as publications on various aspects of people's experience. Dr Turpin has been a teaching and research academic at The University of Queensland for more than 30 years. The connection between theory and practice is central to her research and teaching. As occupational therapists attend to both thinking and experience, they need to use rigorous thinking and a deep understanding of human experience in their practice.

Zephanie is a Senior Research Fellow and occupational therapist based at the Child Health Research Centre, and a member of the management team of the Centre for Children’s Burns and Trauma Research, Brisbane. She has a clinical background specialising in paediatrics and burn care. She has worked clinically and in management positions at Royal Children’s Hospital, Brisbane, in private practice and in research capacity building positions in hospitals and health services.

Since 2013 Zephanie’s research has focussed on developing and validating patient-reported outcome measures, as well as using these measures therapeutically for clinical decision making. She led the development of four versions of the Brisbane Burn Scar Impact Profile which have been translated into Czech and are undergoing cross-cultural validation for Brazilian Portuguese. She has a vision of providing all children and their caregivers with an opportunity to communicate their needs and priorities during treatment in a paediatric hospital or health service.

Her current program of work includes collaborative work with children, their caregivers and health professionals to co-design and test the effectiveness and implementation of technology-based interventions in clinical settings to improve quality of life. These interventions include a web-based intervention for paediatric health professionals to support the psychosocial health of families with a child who has experienced physical trauma, and an electronic intervention for children with skin conditions and their caregivers that provides feedback about the patient's health-related quality of life to health professionals. Zephanie also has a continued interest in investigating the effectiveness and implementation of novel interventions to prevent or improve the impact of skin conditions in children and their families. This includes the use of ablative fractional CO2 laser, medical needling, pressure garment and silicone therapy, medical hypnosis and interventions to promote adherence and reduce the burden of treatment.

Dr. Susannah Tye joined the Queensland Brain Institute in 2017 and has established a research program within the Asia Pacific Centre for Neuromodulation (QLD, Australia). Before returning to Australia, Dr. Tye directed the Translational Neuroscience Laboratory at the Mayo Clinic (2012-2017). While there she led efforts to develop brain stimulation devices (for rodents and humans) that can quantify neural activity and neurotransmitter dynamics in the living brain. This body of work now forms the basis of the neuropsychiatric arm of the Mayo Clinic’s Deep Brain Stimulation Consortium. Her specific research expertise are in utilising voltammetric (electrochemical) recording techniques to monitor rapid, synaptic neurotransmission in the living brain.

Dr. Tye has over ten years of experience studying neuromodulation in preclinical rodent models and human patients. Her long-term goal is to bridge preclinical and clinical studies to maximise translational impact, specifically in terms of improving patient outcomes for those with severe refractory psychiatric illness. Towards this end, she maintains many international collaborations with both clinical and basic science researchers. Dr. Tye also has a longstanding interest in mentoring young scientists to help them expand their skills in preclinical and basic science research and achieve a successful research career.

Children deserve the best of our healthcare. As Professor and Chair in Paediatric Nursing, conjoint between the University of Queensland (UQ) and Children’s Health Queensland, Amanda is working to optimise health service delivery for children in hospital, so they are able to receive the treatment they need, without complications. She also aims to improve the capacity, capability and excellence of consumer-focussed, powerful research across paediatric healthcare.

At UQ, Amanda leads the Paediatric Nursing and Patient Safety research group, which is based across the School of Nursing, Midwifery and Social Work and the Children's Health Research Centre.

Amanda is also co-Chair of the Children's Inpatient Research Colloraborative of Australia and New Zealand (CIRCAN), which facilitates hospital-based paediatric research studies across metropolitan, regional and rural hospitals in Australasia. She is also Director of Child UnLimited, an Australian network of researchers, clinicians, advocates and families with a shared vision: to improve the clinical care and quality of life of children, adolescents and young adults living with a chronic illness or disability.

Mair Underwood is an anthropologist in the School of Social Science who specialises in bodies. In particular she explores how body modifications (such as tattoo or bodybuilding) are used to create, reflect and disrupt social boundaries such as those of gender and class. She is especially interested in the social lives of image and performance enhancing drugs: how they acquire meaning through social interactions and how they alter social interactions.

She also has an interest in assessment practice and has conducted research into assessment techniques that promote student engagement and academic integrity and compiled them into a searchable database called the UQ Assessment Ideas Factory

Mair is passionate about community engagement and engages with the community through her YouTube profile and podcasts such as this one with VPA Australia https://www.vpa.com.au/podcast

Mair Underwood coordinates two courses:

SOSC2190 Human Bodies, Culture and Society

SOCY1060 Gender, Sexuality and Society: An Introduction

Owen Ung is a breast and endocrine surgeon, Director of the Metro North Comprehensive Breast Cancer Institute (CBCI) and Program lead for the Breast Reconstruction at the Herston Biofabrication Institute (HBI). He is a committed clinician, researcher and educator.

Affiliations:

Professor of Surgery, University of Queensland

Royal Brisbane and Women’s Hospital (RBWH)

Surgical Treatment and Rehabilitation Service (STARS)

Brisbane, Queensland, Australia.

Professional representations:

Vice President Royal Australasian College of Surgeons (RACS).

President of Breast Surgery International (BSI), and executive member of the International Surgical Society (ISS).

Fellow of the Australian Institute of Company Directors (FAICD).

Director Medical Insurance Group Australia (MIGA)

Drector Specialist Services Medical Group

Owen has obtained extensive administrative and management experience through his various clinical leadership roles and representations at numerous state, national and international levels. He has over 90 peer reviewed publications and is a lead investigator for a number of significant trials of international significance.

John Upham is a clinical scientist and physician with longstanding research interests in the immunological basis of asthma and chronic lung disease, the role of dendritic cells in allergy and virus infections of the lung, and the development of novel approaches to severe asthma treatment.

John is highly influential in his field, with > 195 publications, > 5,400 citations and an H index of 46. Since 2009, he has 112 publications (1st/senior author on 45%) with a Field-Weighted Citation Impact of 2.03. Moreover, 21.5% of publications are in the top 10% of most-cited publications worldwide (field-weighted). His publications have been cited in >20 different subject areas, demonstrating translation to fields other than Medicine. His research has international reach with citations in 80 countries (Scopus Dec 2018).

In the last 10 years, he has secured over $24 million in research funding. John has been awarded 8 NHMRC Project grants (4 as CIA in the last 5 years), 2 NHMRC CRE (“Closing the gap in Indigenous Lung Health” and “Severe Asthma”), and 1 NHMRC Development Grant. He currently holds NHMRC grants of $7.5 million, including $2.96 million as CIA. John was regularly an invited (9x), plenary (3x) and Chair (9x) at national and international conferences in the last 5 years. In recognition of his international standing and influence in the field, he was elected Fellow of the American Academy of Allergy, Asthma & Immunology (2004) and the Thoracic Society of Australia and New Zealand (2015).

Associate Professor Lata Vadlamudi is a Senior Staff Specialist in Neurology at the Royal Brisbane and Women’s Hospital; Epileptologist within the Comprehensive Epilepsy Program; Metro North Clinician Research Fellow; and Brain, Neurology and Mental health Theme Leader at the University of Queensland Centre for Clinical Research.

She obtained her medical degree from the University of Queensland and completed physician training in the field of Neurology. Further specialized training in epilepsy was undertaken in Melbourne, Sydney and the Mayo Clinic, USA. Her PhD was obtained from the University of Melbourne.

Clinical interests include management of women with epilepsy, particularly during pregnancy with a dedicated women and epilepsy clinic. Other interests include integrating genomics into clinical care with current research projects including developing a Queensland neuro-genomics service to underpin the era of precision-based medicine; and an MRFF-funded project personalising epilepsy regimes with stem cells and artificial intelligence models for superior treatment outcomes.

Awards have included the University of Queensland Centre for Clinical Research Clinician Researcher of the Year, Metro North Clinician Research Fellowship; Highly Commended Clinical Research Award by Metro North Hospital and Health Service, Epilepsy Queensland Health Award for contributions to the medical care of people with epilepsy; and Leonard Cox Award from the Australian and New Zealand Association of Neurologists for outstanding contribution to research in the field of Neurology.

Professor Bruno van Swinderen received his PhD in Evolutionary and Population Biology in 1998 from Washington University in St. Louis, Missouri. His graduate work was on general anesthesia in a Caenorhabditis elegans model, applying both quantitative genetics and molecular genetic approaches. For his postdoc at The Neurosciences Institute (NSI) in San Diego, California (1999-2003), he switched to Drosophila melanogaster to develop methods of studying perception in the fruit-fly model. He ran a lab at NSI from 2003 to late 2007.

Professor van Swinderen established a new laboratory at the Queensland Brain Institute in February 2008.

Bruno van Swinderen's group use Drosophila as a genetic model system to study mechanisms of perception in the brain and are interested in three phenomena: selective attention, sleep, and general anesthesia. Their focus is on visual perception and how it is affected by these different arousal states. Their current effort is in understanding how sleep regulates selective attention and predictive processing. Toward this goal, they use various novel visual paradigms in a Drosophila molecular genetics context. The lab is also focussed on understanding presynaptic mechamisms of general anaesthesia, with a view to uncovering new strategies to improve recovery from this common medical procedure.

David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.

His main research interests are in the area of renal tubulointerstitial fibrosis, inflammation and also the mechanisms of renal cancer development – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in renal scarring, inflammation and cancer, the mechanism of heavy metal toxicity in the kidney and the renoprotective properties of erythropoietin. The Princess Alexandra Hospital Endotoxin Testing Service routinely tests samples from dialysis units throughout Queensland.

I am an NHMRC Leadership Fellow with joint apointments at the Institute for Molecular Bioscience (IMB) and School of Pharmacy, UQ. My research interests lie in the fields of peripheral pain mechanisms, target identification and analgesic drug discovery. I investigate the contribution of ion channels to sensory neuronal physiology using highly subtype-selective toxins isolated from venomous animals with the aim to develop novel analgesics with improved efficacy and tolerability.

I am a Professor Emeritus in Sports Physiotherapy in the School of Health and Rehabilitation Sciences where I am the Director of the Master of Physiotherapy (Musculoskeletal and Sports Physiotherapy Majors) and co-Director of the Sports Injury Rehabilitation and Prevention for Health Research unit. My research is mainly focussed on non-surgical management of persistent musculoskeletal problems like tendon related pain/disability (tendinopathy) and knee cap pain (patellofemoral pain). I also delve into the underlying mechanisms of these conditions and other common sporting injuries (e.g., ankle sprains) – a leading cause of ankle osteoarthritis.

Since gaining my PhD in 2000, I have been awarded over $30million in competitive research funding as a chief investigator to study these conditions – 5 NHMRC project grants, 2 NHMRC CRE, 2 NHMRC program grants, 2 NHMRC MRFF grants and an ARC Linkage grant. I have also conducted over half a million dollars of commercially sponsored research.

I have authored 2 books, 26 book chapters and over 382 peer reviewed publications (h-index 68). My top tendinopathy papers are cited over 10 times more than average for the field – most are published in the top sports/general medicine and physiotherapy journals . I have 2 highly cited papers – in the top 1% of the academic field of Clinical Medicine 2022. I have presented my work world wide in over 300 workshops, seminars and keynote presentations.

I enjoy my role in mentoring early/mid career academics and supervising researh higher degree students – having supervised 40 PhD and 2 MPhil candidates to completion. In this capacity I lead the physiotherapy research higher degree seminar series where our students engage in presenting their work and hearing from top international researchers on a range of relevant topics. One reason why my work was recently recognised by the school award for research mentoring.

Dwan is an environmental epidemiologist, with a particular interest in children's environmental health. Her current research explores the following:

• Environmentally persistent free radicals, air pollution, and children's lung outcomes
• Maternal exposure to green space, ambient temperature and air pollution and the association with neonatal and child outcomes
• The knowledge of GPs and naturopaths on environmental health issues for preconception care
• Exposures to phthalates and allergic disease

Dwan has a background in public health and nutrition. She is a founder and co-host of the R Peer Group at UQ/QIMR